Alterations of microRNAs and their targets are associated with acquired resistance of MCF-7 breast cancer cells to cisplatin.
about
Microparticle conferred microRNA profiles--implications in the transfer and dominance of cancer traitsClinical Potential of microRNA-7 in CancerThe effects of microRNA on the absorption, distribution, metabolism and excretion of drugsMicroRNAs in breast cancer initiation and progressionNon-coding RNAs as theranostics in human cancersMicroRNA in cancer: new hopes for antineoplastic chemotherapyMiR-200, a new star miRNA in human cancerThe miR-200 and miR-221/222 microRNA families: opposing effects on epithelial identityExploring circulating micro-RNA in the neoadjuvant treatment of breast cancerExosomes-mediate microRNAs transfer in breast cancer chemoresistance regulationApoptomiRs of Breast Cancer: Basics to ClinicsMiRNAs and miRNA Polymorphisms Modify Drug ResponseThe microRNA-200 family: small molecules with novel roles in cancer development, progression and therapy3, 3'-Diindolylmethane enhances the effectiveness of herceptin against HER-2/neu-expressing breast cancer cellsmiR-200c sensitizes breast cancer cells to doxorubicin treatment by decreasing TrkB and Bmi1 expressionChanges in the expression of miR-381 and miR-495 are inversely associated with the expression of the MDR1 gene and development of multi-drug resistanceTime-resolved cell culture assay analyser (TReCCA Analyser) for the analysis of on-line data: data integration--sensor correction--time-resolved IC50 determinationmiR-8 modulates cytoskeletal regulators to influence cell survival and epithelial organization in Drosophila wings.Association between DNA methylation in the miR-328 5'-flanking region and inter-individual differences in miR-328 and BCRP expression in human placentaEpigenetic silencing of microRNA-199b-5p is associated with acquired chemoresistance via activation of JAG1-Notch1 signaling in ovarian cancer.Association of microRNAs and pathologic response to preoperative chemotherapy in triple negative breast cancer: preliminary reportMicroRNAs in pathogenesis of breast cancer: Implications in diagnosis and treatment.Downregulation of eIF4G by microRNA-503 enhances drug sensitivity of MCF-7/ADR cells through suppressing the expression of ABC transport proteins.MicroRNA-mRNA functional pairs for cisplatin resistance in ovarian cancer cells.Molecular mechanisms of acquired resistance to tyrosine kinase targeted therapyMicro-RNAs as Potential Predictors of Response to Breast Cancer Systemic Therapy: Future Clinical Implications.Members of the microRNA-200 family are promising therapeutic targets in cancer.Pharmaco-miR: linking microRNAs and drug effects.Down-regulation of BRCA1 expression by miR-146a and miR-146b-5p in triple negative sporadic breast cancers.Trastuzumab produces therapeutic actions by upregulating miR-26a and miR-30b in breast cancer cells.RAB8 enhances TMEM205-mediated cisplatin resistance.MAGIA²: from miRNA and genes expression data integrative analysis to microRNA-transcription factor mixed regulatory circuits (2012 update).Repression of NR4A1 by a chromatin modifier promotes docetaxel resistance in PC-3 human prostate cancer cells.miRNAs associated with chemo-sensitivity in cell lines and in advanced bladder cancerSmall players with big roles: microRNAs as targets to inhibit breast cancer progression.MiR-634 sensitizes nasopharyngeal carcinoma cells to paclitaxel and inhibits cell growth both in vitro and in vivoCell-specific post-transcriptional regulation of γ-synuclein gene by micro-RNAs.Sequential Salinomycin Treatment Results in Resistance Formation through Clonal Selection of Epithelial-Like Tumor Cells.Aberrant microRNA expression in endometrial carcinoma using formalin-fixed paraffin-embedded (FFPE) tissues.Identification and validation of miRNAs as endogenous controls for RQ-PCR in blood specimens for breast cancer studies.
P2860
Q21245759-6CE12606-E06E-4A58-9AA4-6BF077EE80CBQ26797306-888E478D-7538-45CE-BD89-E23C0FC13623Q26822987-5DF007AF-72FE-463C-AE71-5A5742A69CE6Q26823360-A0158AB7-03FC-4CAB-9EF4-F558750DD7EFQ26851250-8878E53F-8262-4BB3-B819-3B54A7AA13F0Q27001048-5DB52727-FB62-4D87-8495-34F48F811CB1Q27004023-1FAA803D-21DB-404A-A9B7-75E874902A92Q27010233-76D2C88D-F439-4A75-8E05-D60BB84EAA77Q28066481-D5F9F2EC-77EE-408B-A883-1C1B549218F7Q28066991-4DC8EDCB-01C0-4927-8480-DA90A70ECBF2Q28072414-79A3241F-8768-4036-A922-BD6A34887DB7Q28079075-F3705460-ED8A-4551-A344-7E16A7101E6AQ28083742-7A030653-7EE6-43CE-8DE7-796D54E4161AQ28485231-09DF47FF-E281-44EB-90FC-C4D676FC5910Q28485384-486AE91C-ABAB-4AA1-923E-78A5B2E85807Q28535423-0FB97B60-7FA3-4AC4-93A8-F6626C09FFD3Q28545774-F8D6BD6E-8E37-408B-A5F9-A56084F081E4Q30359720-3A1A417D-248E-45DD-B61E-059CE28DEFA1Q31133417-1D6BB108-1BE2-406C-B8AA-9548216E0590Q33572313-52B5FE55-6314-433C-A196-BFB4D53663ABQ33579853-BE9C7A5E-87E0-4982-B8B3-58EB6473EE4DQ33585094-C38E5F39-ECC4-47AC-89D4-946CD51CEDCFQ33751074-4A2970B7-8865-4537-A163-F3137F5A87C0Q33764106-D216184A-57F6-496E-A7E0-43BBAA84F590Q33828409-6B14AD53-6A1F-4C49-AA0E-7813E73E30BDQ33838622-88EA5CB5-44CD-44F1-A3CD-A79FD228593FQ33846551-705E540E-F073-4FD1-B6A7-A7ADAD9FD3CCQ33920265-5112E377-3443-4B17-975F-5F9E52DD2DA1Q34176503-DE280280-8956-4009-8865-5B7C6AE1FD64Q34181700-BBC93A52-BE37-4A53-8132-FB20274FCF8BQ34221132-448C79B4-32BD-4591-9EA6-FC5DC8067D90Q34278592-FF51C595-7BDA-46A2-AB38-749E38C38908Q34355852-E3AD677F-107B-4C16-BE34-FD5F08BFC1A6Q34407238-21534283-A320-4AFD-8A94-FF467F46C18DQ34425882-2CD969D7-D15F-47CA-A130-A17B2C6F4D2EQ34501681-3F79F407-A13C-4D5B-9C0C-D3E2640535DFQ34989307-14E1A9A2-EAF8-47B1-A5DC-493DB85AA772Q35028765-6CE64FBE-98F0-491B-A341-B674121EBD7BQ35074362-5799CC4F-9B15-49EA-A2DC-8243A1621C87Q35082591-7B217C44-35CA-44A8-A8E5-B61DE91A22F7
P2860
Alterations of microRNAs and their targets are associated with acquired resistance of MCF-7 breast cancer cells to cisplatin.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Alterations of microRNAs and t ...... ast cancer cells to cisplatin.
@ast
Alterations of microRNAs and t ...... ast cancer cells to cisplatin.
@en
Alterations of microRNAs and t ...... ast cancer cells to cisplatin.
@nl
type
label
Alterations of microRNAs and t ...... ast cancer cells to cisplatin.
@ast
Alterations of microRNAs and t ...... ast cancer cells to cisplatin.
@en
Alterations of microRNAs and t ...... ast cancer cells to cisplatin.
@nl
prefLabel
Alterations of microRNAs and t ...... ast cancer cells to cisplatin.
@ast
Alterations of microRNAs and t ...... ast cancer cells to cisplatin.
@en
Alterations of microRNAs and t ...... ast cancer cells to cisplatin.
@nl
P2093
P356
P1476
Alterations of microRNAs and t ...... ast cancer cells to cisplatin.
@en
P2093
Andrey Golubov
Igor P Pogribny
Jody N Filkowski
Olga Kovalchuk
Svitlana I Shpyleva
P2860
P304
P356
10.1002/IJC.25191
P577
2010-10-01T00:00:00Z